Hiroaki Shibata

1.4k citations
59 papers · 1.0k indexed · h-index 19
Topics
Virus-based gene therapy research (14 papers)CRISPR and Genetic Engineering (13 papers)RNA Interference and Gene Delivery (9 papers)

In The Last Decade

Hiroaki Shibata

58 papers receiving 994 citations

Peers

Hiroaki Shibata
Comparison fields: 5 of 101
  • Molecular Biology 467
  • Genetics 211
  • Immunology 184
  • Surgery 154
  • Genetics 151
Replace Anoop Kavirayani with:
Anoop Kavirayani Austria
A. Hildebrand Germany
Paul H. Ehrlich United States
Bernadette Ferraro United States
Farbod Babrzadeh United States
Maja M. Suter Switzerland
Angela Rösen‐Wolff Germany
Julien Burlaud‐Gaillard France
John F. Whitesides United States
Geoffrey Y. Akita United States
Hiroaki Shibata relative to Anoop Kavirayani Austria Anoop Kavirayani's profile →
Citations per field
00.5×3.5×
Anoop Kavirayani · 1×
Citations per year

Countries citing papers authored by Hiroaki Shibata

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Shibata more than expected).

Fields of papers citing papers by Hiroaki Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Shibata. The network helps show where Hiroaki Shibata may publish in the future.

Co-authorship network of co-authors of Hiroaki Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Shibata. A scholar is included among the top collaborators of Hiroaki Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Shibata. Hiroaki Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 5
4 8
5 11
6 11
7 18
8 39
9 2
10 35
11 6
12 10
13 18
14 8
15 14
16 5
17 14
18 26
19 30
20 9

About Hiroaki Shibata

Hiroaki Shibata is a scholar working on Virology, Genetics and Genetics, having authored 59 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CRISPR and Genetic Engineering (13 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Virology (84 citations), Genetics (151 citations) and Immunology (184 citations). Hiroaki Shibata has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Keiji Terao, Yutaka Hanazono, Naohide Ageyama, Keiya Ozawa, Fumiko Ono, Yasuji Ueda, Yasuhiro Yoshikawa, Yasuhiro Yasutomi, Hirofumi Akari and Ki‐Hoan Nam. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026